Osseous Outcomes of Cleft Alveolar Bone Grafting with Allograft and Platelet-Rich Fibrin: Preliminary Study with Radiological Outcome
The Cleft Palate Craniofacial Journal · 2025
DOI: 10.1177/10556656241271663 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Cleft Palate Craniofacial Journal, 2025. Verfasst von Julie Chauvel-Picard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cranio-Maxillo-Facial Surgery, Hôpital Femme Mère Enfant, Lyon Bron, France. Hauptthemen laut MEDLINE: Cleft Palate, Alveolar Bone Grafting, Platelet-Rich Fibrin, Bone Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
Cleft lip and palate are the most common craniofacial malformations worldwide. The alveolar cleft is treated with a bone graft, between 4 and 7 years of age in mixed dentition. This is an important step because it provides good quality jawbone and a better support of the lip and the alar cartilage on the side of the cleft. Bone autografting with iliac harvesting remains the most commonly used technique, but it is not without risks. Allograft techniques have therefore been described to reduce this morbidity (pain, infectious risk, hemorrhagic risk, fracture risk). The aim of this study was to evaluate, one year after allografting, the efficiency and consolidation of the bone allograft in the alveolar cleft.
Setting
A retrospective study was conducted in the department of pediatric craniomaxillofacial surgery in the Woman-Mother-Child Hospital in Lyon, France. Patients This series includes 22 patients or 25 alveolar cleft bone grafts, including 16 boys and 6 girls, with an average age of 6.1 years. Main Outcome Measures Quantify the residual bone allograft by evaluating the ratio between the volume of the bone graft and the volume of the initial space on pre- and post-operative cone beam computed tomography.
Results
The residual bone allograft percentage at 1 year was 58.5% (± 22.3).
Conclusions
Alveolar cleft bone graft with bone allograft is an alternative to iliac autografting to reduce donor site morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cranio-Maxillo-Facial Surgery, Hôpital Femme Mère Enfant, Lyon Bron, France.
- Department of Cranio-Maxillo-Facial Surgery, Centre Hospitalo-Universitaire Nord, Saint-Etienne, France.
- Université Jean Monnet, Saint-Étienne, France.
- Department of cranio-maxillo-facial surgery, Hôpital de la Croix Rousse, Lyon, France.
- Université Claude Bernard Lyon 1, Villeurbanne, France.
ORCID-Profile: Julie Chauvel-Picard, Camille Lambert
Zitieren
APA
Chauvel-Picard, J., Lambert, C., Gaget, D., Asselborn, M., Lange, E., & Gleizal, A. (2025). Osseous Outcomes of Cleft Alveolar Bone Grafting with Allograft and Platelet-Rich Fibrin: Preliminary Study with Radiological Outcome. The Cleft Palate Craniofacial Journal. https://doi.org/10.1177/10556656241271663
Vancouver
Chauvel-Picard J, Lambert C, Gaget D, Asselborn M, Lange E, Gleizal A. Osseous Outcomes of Cleft Alveolar Bone Grafting with Allograft and Platelet-Rich Fibrin: Preliminary Study with Radiological Outcome. The Cleft Palate Craniofacial Journal. 2025. doi:10.1177/10556656241271663
BibTeX
@article{ChauvelPicard2025,
author = {Chauvel-Picard, Julie and Lambert, Camille and Gaget, Dominique and Asselborn, Marc and Lange, Edouard and Gleizal, Arnaud},
title = {Osseous Outcomes of Cleft Alveolar Bone Grafting with Allograft and Platelet-Rich Fibrin: Preliminary Study with Radiological Outcome},
journal = {The Cleft Palate Craniofacial Journal},
year = {2025},
doi = {10.1177/10556656241271663}
}
EUVIMED